FDA Drug Recalls

Recalls / Class II

Class IID-0593-2021

Product

HALOPERIDOL TABLETS 20mg, USP, 100-count bottle, Rx Only Distributed by: Usher-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC: 0832-1560-11

Brand name
Haloperidol
Generic name
Haloperidol
Active ingredient
Haloperidol
Route
Oral
NDCs
0832-1510, 0832-1520, 0832-1530, 0832-1540, 0832-1550, 0832-1560
FDA application
ANDA211061
Affected lot / code info
2007346C

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Recalling firm

Firm
Cardinal Health Inc.
Manufacturer
Upsher-Smith Laboratories, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7000 Cardinal Pl, N/A, Dublin, Ohio 43017-1091

Distribution

Quantity
35 BOTTLE
Distribution pattern
FL, GA, SC

Timeline

Recall initiated
2021-03-15
FDA classified
2021-05-24
Posted by FDA
2021-06-02
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0593-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.